×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TEVA – teva pharmaceutical industries limited american depositary shares (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TEVA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
04:30 pm
teva
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
Neutral
Report
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
12/20
05:00 am
teva
My Top 10 Portfolio Holdings for 2025 [Yahoo! Finance]
Medium
Report
My Top 10 Portfolio Holdings for 2025 [Yahoo! Finance]
12/18
11:06 pm
teva
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
12/18
10:19 am
teva
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $25.00 to $28.00. They now have an "overweight" rating on the stock.
Low
Report
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $25.00 to $28.00. They now have an "overweight" rating on the stock.
12/18
08:48 am
teva
Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength? [Yahoo! Finance]
Low
Report
Strength Seen in Teva Pharmaceutical Industries (TEVA): Can Its 26.5% Jump Turn into More Strength? [Yahoo! Finance]
12/17
04:40 pm
teva
Teva and Sanofi jump on experimental bowel disease drug success [Yahoo! Finance]
Low
Report
Teva and Sanofi jump on experimental bowel disease drug success [Yahoo! Finance]
12/17
07:30 am
teva
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
High
Report
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
07:00 am
teva
teva pharmaceutical industries limited american depositary shares
BEAT
Report
-10.8%
teva pharmaceutical industries limited american depositary shares
7/31/2024
07:00 am
teva
teva pharmaceutical industries limited american depositary shares
BEAT
Report
3.6%
teva pharmaceutical industries limited american depositary shares
5/8/2024
07:00 am
teva
teva pharmaceutical industries limited american depositary shares
MISS
Report
9.3%
teva pharmaceutical industries limited american depositary shares
1/31/2024
07:00 am
teva
teva pharmaceutical industries limited american depositary shares
BEAT
Report
1.8%
teva pharmaceutical industries limited american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/20
07:03 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: BRIDGER MANAGEMENT, LLC
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: BRIDGER MANAGEMENT, LLC
12/4
04:08 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 02 Filed by: Lichtenstein Chen
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 02 Filed by: Lichtenstein Chen
12/4
04:05 pm
teva
Form 3 TEVA PHARMACEUTICAL INDU For: Dec 01 Filed by: Lichtenstein Chen
Low
Report
Form 3 TEVA PHARMACEUTICAL INDU For: Dec 01 Filed by: Lichtenstein Chen
11/21
04:05 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Nov 20 Filed by: Fox Christine
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Nov 20 Filed by: Fox Christine
11/20
11:39 am
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Fox Christine
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Fox Christine
11/12
04:32 pm
teva
Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 05
Low
Report
Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 05
11/12
10:35 am
teva
Form SC 13G TEVA PHARMACEUTICAL INDU Filed by: FMR LLC
Low
Report
Form SC 13G TEVA PHARMACEUTICAL INDU Filed by: FMR LLC
11/6
04:07 pm
teva
Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30
Low
Report
Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/18
Shortage of critical children’s cancer drug causes concerns nationwide [MSNBC.com]
16.9%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
TOP News Decliners
5/11
U.S. states sue Teva, 19 other drug companies in price-fixing complaint [Reuters (UK)]
-14.7%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: